California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, invites members of the press to attend the 2019 CLSA Pantheon DiNATM Awards, a distinguished program that honors and recognizes the impact that California’s therapeutic, diagnostic, medical device, and industrial biotechnology companies are making in California and for patients around the globe
CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices
Life Sciences Trade Groups Warn Congress: International Reference Pricing Proposals Included in Bills like H.R. 3 Undermine Hope for Patients and America’s Leadership in Biomedical Innovation
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, has announced that Dr. Jennifer Doudna, a visionary leader in CRISPR gene editing technology and nominee for Nobel Prize in Chemistry, will receive the 2019 Life Sciences Leadership Award, a prestigious award to be presented at CLSA’s 2019 Pantheon DiNA Program. The Pantheon Awards honors California’s most innovative and dedicated life sciences leaders for their ongoing contributions to California’s life sciences sector.
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, has announced the 2019 Pantheon DiNATM Awards slate of honorees. Through the premier awards program, CLSA annually recognizes excellence in the California life sciences sector and celebrates the contributions and achievements of leading life sciences innovators in the state.
Instead of importing foreign price controls and restricted access policies, Congress should work to lower out-of-pocket costs so that patients can afford the treatments they need and preserve incentives for innovation
New Members and Representation from Amgen, Ardelyx, Boehringer Ingelheim, Cortexyme, DuPont Nutrition & Biosciences, Ernst & Young, GRAIL, Medtronic, Nkarta Therapeutics
CLSA to Host Leaders of BIO, PhRMA, AdvaMed & Johnson & Johnson Innovation | JLABS for Discussion on Life Sciences Leadership, Policy & Direction
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, issued the following statement in response to the Trump Administration’s drug importation proposal unveiled today.
Today, CLSA announced a new life sciences credit card member benefit through its partnership with Brex, the corporate card built for the life sciences that accelerates entrepreneurs and scaling businesses.